Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids

Alaa M Afify, Basim M. Al-Khafaji

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

OBJECTIVE: To evaluate the diagnostic utility of the immunohistochemical expression of thyroid transcription factorr-1 (TTF-1) in adenocarcinomas from serous fluid specimens. STUDY DESIGN: Archival paraffin-embedded cell blocks of serous fluids from 82 cases, including 34 cases of metastatic lung adenocarcinoma, 12 of metastatic ovarian adenocarcinoma, 12 of metastatic breast adenocarcinoma, 12 of metastatic gastrointestinal adenocarcinoma and 12 of malignant mesothelioma, were immunostained with anti-TTF-1. All the staining was carried out using a Ventana Automated System. Staining was evaluated according to the intensity of the nuclear staining (1+ to 4+) by two observers. RESULTS: Of the metastatic lung adenocarcinomas, 79% (27/34) expressed 3+ to 4+ reactivity against TTF-1. None of the malignant mesotheliomas or other metastatic adenocarcinomas expressed nuclear reactivity. CONCLUSION: Immunostaining with TTF-1 is a useful marker that can be applied to cytologic specimens. Anti-TTF-1 can be used as a reliable component of an antibody panel to support the diagnosis of adenocarcinoma of pulmonary origin in patients presenting with metastatic adenocarcinoma in serous fluid with an unknown primary site.

Original languageEnglish (US)
Pages (from-to)675-678
Number of pages4
JournalActa Cytologica
Volume46
Issue number4
StatePublished - 2002
Externally publishedYes

Fingerprint

Adenocarcinoma
Thyroid Gland
Staining and Labeling
thyroid nuclear factor 1
Paraffin
Breast
Lung
Antibodies
Malignant Mesothelioma
Adenocarcinoma of lung

Keywords

  • Adenocarcinoma
  • Serous fluids
  • TTF-1

ASJC Scopus subject areas

  • Anatomy
  • Cell Biology
  • Histology

Cite this

Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids. / Afify, Alaa M; Al-Khafaji, Basim M.

In: Acta Cytologica, Vol. 46, No. 4, 2002, p. 675-678.

Research output: Contribution to journalArticle

@article{e069b7e54ccc4e349e6a2e06632ad1e0,
title = "Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids",
abstract = "OBJECTIVE: To evaluate the diagnostic utility of the immunohistochemical expression of thyroid transcription factorr-1 (TTF-1) in adenocarcinomas from serous fluid specimens. STUDY DESIGN: Archival paraffin-embedded cell blocks of serous fluids from 82 cases, including 34 cases of metastatic lung adenocarcinoma, 12 of metastatic ovarian adenocarcinoma, 12 of metastatic breast adenocarcinoma, 12 of metastatic gastrointestinal adenocarcinoma and 12 of malignant mesothelioma, were immunostained with anti-TTF-1. All the staining was carried out using a Ventana Automated System. Staining was evaluated according to the intensity of the nuclear staining (1+ to 4+) by two observers. RESULTS: Of the metastatic lung adenocarcinomas, 79{\%} (27/34) expressed 3+ to 4+ reactivity against TTF-1. None of the malignant mesotheliomas or other metastatic adenocarcinomas expressed nuclear reactivity. CONCLUSION: Immunostaining with TTF-1 is a useful marker that can be applied to cytologic specimens. Anti-TTF-1 can be used as a reliable component of an antibody panel to support the diagnosis of adenocarcinoma of pulmonary origin in patients presenting with metastatic adenocarcinoma in serous fluid with an unknown primary site.",
keywords = "Adenocarcinoma, Serous fluids, TTF-1",
author = "Afify, {Alaa M} and Al-Khafaji, {Basim M.}",
year = "2002",
language = "English (US)",
volume = "46",
pages = "675--678",
journal = "Acta Cytologica",
issn = "0001-5547",
publisher = "Science Printers and Publishers Inc.",
number = "4",

}

TY - JOUR

T1 - Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids

AU - Afify, Alaa M

AU - Al-Khafaji, Basim M.

PY - 2002

Y1 - 2002

N2 - OBJECTIVE: To evaluate the diagnostic utility of the immunohistochemical expression of thyroid transcription factorr-1 (TTF-1) in adenocarcinomas from serous fluid specimens. STUDY DESIGN: Archival paraffin-embedded cell blocks of serous fluids from 82 cases, including 34 cases of metastatic lung adenocarcinoma, 12 of metastatic ovarian adenocarcinoma, 12 of metastatic breast adenocarcinoma, 12 of metastatic gastrointestinal adenocarcinoma and 12 of malignant mesothelioma, were immunostained with anti-TTF-1. All the staining was carried out using a Ventana Automated System. Staining was evaluated according to the intensity of the nuclear staining (1+ to 4+) by two observers. RESULTS: Of the metastatic lung adenocarcinomas, 79% (27/34) expressed 3+ to 4+ reactivity against TTF-1. None of the malignant mesotheliomas or other metastatic adenocarcinomas expressed nuclear reactivity. CONCLUSION: Immunostaining with TTF-1 is a useful marker that can be applied to cytologic specimens. Anti-TTF-1 can be used as a reliable component of an antibody panel to support the diagnosis of adenocarcinoma of pulmonary origin in patients presenting with metastatic adenocarcinoma in serous fluid with an unknown primary site.

AB - OBJECTIVE: To evaluate the diagnostic utility of the immunohistochemical expression of thyroid transcription factorr-1 (TTF-1) in adenocarcinomas from serous fluid specimens. STUDY DESIGN: Archival paraffin-embedded cell blocks of serous fluids from 82 cases, including 34 cases of metastatic lung adenocarcinoma, 12 of metastatic ovarian adenocarcinoma, 12 of metastatic breast adenocarcinoma, 12 of metastatic gastrointestinal adenocarcinoma and 12 of malignant mesothelioma, were immunostained with anti-TTF-1. All the staining was carried out using a Ventana Automated System. Staining was evaluated according to the intensity of the nuclear staining (1+ to 4+) by two observers. RESULTS: Of the metastatic lung adenocarcinomas, 79% (27/34) expressed 3+ to 4+ reactivity against TTF-1. None of the malignant mesotheliomas or other metastatic adenocarcinomas expressed nuclear reactivity. CONCLUSION: Immunostaining with TTF-1 is a useful marker that can be applied to cytologic specimens. Anti-TTF-1 can be used as a reliable component of an antibody panel to support the diagnosis of adenocarcinoma of pulmonary origin in patients presenting with metastatic adenocarcinoma in serous fluid with an unknown primary site.

KW - Adenocarcinoma

KW - Serous fluids

KW - TTF-1

UR - http://www.scopus.com/inward/record.url?scp=0036071202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036071202&partnerID=8YFLogxK

M3 - Article

C2 - 12146029

AN - SCOPUS:0036071202

VL - 46

SP - 675

EP - 678

JO - Acta Cytologica

JF - Acta Cytologica

SN - 0001-5547

IS - 4

ER -